| | | | | | . 10 . 20 . 30 . 40 . 50 . 60 . 70 . 80 . 90 . 100 . 110 . 120 . 130 . 140 . 150 . 160 . 170 . 180 . 190 . 200 . 210 . 220 . 230 . 240 . 250 . 260 . 270 . 280 . 290 . 300 . 310 . 320 . 330 . 340 . 350 . 360 . 370 . 380 . 390 . 400 . 410 . 420 . 430 . 440 . 450 |
| # |
Score |
Template |
Links and tools | %id | First |
MSWSVTLNQLIEVLLARPVNISEAALTQVSSGIQTDTRMIKPGEVFLAFRGEKFDGHEFISSAIARGAIAAIVDDDYENPGLPVLQVSNTLEAYQKLGRWWRDRFDIPVIGVTGSVGKTTTKELIAAVLGTKGNVLKTYGNYNNEIGVPKTLLELNAEHDYAVIEMAMRGRGQIAELAQIARPTIGVITNVGTAHIELLGSEEAIAEAKCELLAEMPKDSVAILNHDNPLLMATAAKFWSGEVLTYGLSGGDVQGSLVDNAIVEVAGLRLPLPLPGRHNATNYLAALAVAKVLGIEWSSLQAGVSVNMPTGRSQRFSLPNDVLILDETYNAAPEAMLAALQLLADTPGKRKIAVLGAMKELGERSAQLHQRVGETVRNLKLDGLLVLVDGEDAEAIARSAEGIPSECFATHADLVARLTTFVQGGDRLLFKAAHSVGLDRVVSQLRAEFSN | Last |
| 1 | -131.000 | [M] COG0770 UDP-N-acetylmuramyl pentapeptide synthase |
ali |
100 | 1 | MSWSVTLNQLIEVLLARPVNISEAALTQVSSGIQTDTRMIKPGEVFLAFRGEKFDGHEFISSAIARGAIAAIVDDDYENPGLPVLQVSNTLEAYQKLGRWWRDRFDIPVIGVTGSVGKTTTKELIAAVLGTKGNVLKTYGNYNNEIGVPKTLLELNAEHDYAVIEMAMRGRGQIAELAQIARPTIGVITNVGTAHIELLGSEEAIAEAKCELLAEMPKDSVAILNHDNPLLMATAAKFWSGEVLTYGLSGGDVQGSLVDNAIVEVAGLRLPLPLPGRHNATNYLAALAVAKVLGIEWSSLQAGVSVNMPTGRSQRFSLPNDVLILDETYNAAPEAMLAALQLLADTPGKRKIAVLGAMKELGERSAQLHQRVGETVRNLKLDGLLVLVDGEDAEAIARSAEGIPSECFATHADLVARLTTFVQGGDRLLFKAAHSVGLDRVVSQLRAEFSN |
451 |
| 2 | -48.200 | [M] COG0769 UDP-N-acetylmuramyl tripeptide synthase |
ali follow.. |
21 | 1 | ....MKLRELLATVDSVEN-LPPVLADAEVKGIKTNSHACGAGDLFIGMPGTRVDGGEFWPSAIASGAIAAIVSPQAVHDEAVVISSNNMTKACAAIAAAFYGY-KLKLVGVTGTNGKTTTTHLIEFFLTKAKLSTALMGTLYTRWP-AVELQQQNAGCEFGVMEVS-SHALAQGRVLGCP--EVGVFSNLTQDHLDYHSDMEDYFAAKALLFSPEYLKGRAIINADDTYGQRLIKALSPEKVWSYSVNDADLWMSDLGTIHTPEGNVSFRSPLVGQYNLENLLAAVGAVLHLGLNLQLIANAIPEFPGVPGRMERVQINPISVIVD-YAHTPDSLENLLKAARPFIPGRMICVFG-----GDRDRTKRPKMGKIVAELA-DLAFVTSDNPRTEDLAGIPDTVQPTVIGDRAIAIRTAILQAQPGDGVLLAG-KGHEDYQILGTEKIHFDD |
482 |
| 3 | -34.100 | [M] COG0771 UDP-N-acetylmuramoylalanine-D-glutamate ligase |
ali follow.. |
21 | 8 | ..............................................ILVAGLGGTGISMIAYLRKNGAEVAAYDAELKPERVSQIGISERQPDIEELLADIVNRRDDKVIAITGSNGKTTVTSLVGYLCIKCGLDTVIAGN----IGTPVLEAEWQREADVWVLELSSFQLENTESL----RPTAATVLNISEDHLDRYDDLLDYAHTKAKIFRG---DGVQVLNADDAFCRAMKR--AGREVKWFSLEHEADFWLERETGRLKQGNEDLDIPLQGLHNAANVMAAVALCEAIGLSREALLEHVKTFQGLPHRVEIGEKNGVVFIDDSKGTNVGATAAAIAGLQ----NPLFVILG-----GMGKGQDFTPLRDALVGK-AKGVFLIGVDAPQIRRDLDGCGLNMTDCATLGEAVQTAYAQAEAGDIVLLSPARSEVFIEAFKAL...... |
445 |
| 4 | -29.000 | [M] COG0773 UDP-N-acetylmuramate-alanine ligase |
ali follow.. |
19 | 51 | .............................IGGVGMSGIAEVLHNLGFKVSGSDQARNAATEHLGSLGIQVYPGHTAEHVNGADVVVTSTAVLMLAELMRFRDG------IAIAGTHGKTTTTSLTASIL--------GAAGLDPTFVIGGKLNAAGTNARLGKGEYIVAEADESDASFLHLTPIMSVVTNIDEDHMDTYGSVEKLHQAFIDFIHRMPFYGKAFLCIDSEHVRAILPKV-SKPYATYGLDTADIYATDIEMKGHEQGSFEVVLNMPGRHNVLNALAAIGVALEVGASVEAIQKGLLGFEGVGRRFQKYNGGTALLVDD-YGHHPVEMAATLSAARGAYPEKRLVLA----HRYTRTRDLFEDFTKVLNTVDALVLTEVADSRALARAIRVLGKLEPIYCENVADLPEMLLNVLQDGDIVLNMGA---SINRVPAALLELSKQ |
505 |
| 5 | -20.500 | [H] COG0285 Folylpolyglutamate synthase |
ali follow.. |
15 | 20 | ......................................................................................IDMGLERTSEVKKRMKLEPQCPVVVVAGTNGKGSVCAYLTQIYKQAGYKIGTLTSYNERIEISLTYFEFREQVDVMILEVGLG--GRLDA-VNAFDGDCAVVTSVDLDHQAFLGTVEQVGFEKAGVFR----SGKPAICGQNPAPKSLLSHAEAIGAFEFHAMENIQWNYRFRPQHSDDPARNRNPALRGTYQLSNAACALTVLECLNVDIGAIKRGLLLVENPG-RFQVLPGRPLTVLDVGHN--PHAARALRRSLINLAFAQKRTAV-----FSMLSDKDIDGVLETVKDQFDEWYIAPLDVPRGQNKLHEHSIENIQTFAAVREAYRAAASKAGENDRIVVFGS.................. |
413 |
| 6 | -17.800 | [H] KOG2525 Folylpolyglutamate synthase |
ali follow.. |
15 | 59 | ......................................................................................MVEMRHWLRCIGYQPSDLNRLNVIHVAGTKGKGSTCAFTSSILQQIQKSGERSIPKC--IGMPLTLMAWSENVDAAIIEVGIG--GEYDSTNLIEKPYATAVTSLGLDHTSLLGTIAEIAWQKAGIY----KESAIALTCEQA-----------PEAMNVLKNRAAERNTSLKVVIPPAELTPDMIGLSGVHQLGNTSLAVSLVQEFPYQDPAILDGLKYVKWPGRCQIEEINNIKWCFDGAHT--KESLEATGLWLASKDADARILLFNQQSRDDPIARSFLKGLESSGTGISFTHVIFSTNVTWKDAGYNPGTTSEATVAPTIQEAIETVMSIKQRNTFVCVTGSLHL-TGGVFVVLDQAV.. |
504 |
| 7 | -8.860 | [S] COG3367 Uncharacterized conserved protein |
ali follow.. |
15 | 63 | ..........................DVPVVSSVEKAKEMGAEVLIISNPGGYLQIATLVKKALSLGMDVISGLHFKISQQTEFTRIIDIRIPPLELDVLRGGRKKIKVVGVFGTDGKRTTAVQLWERALEKGIKAGFLATGQTGIVVEKAVLKLEKTGKEIVFVEGQGALRHPAYLLYGSNPDVVFLHDPSRDHFESFPEIPKKFEEERRLIETLSNAKVIGLNGGFET............................................................................................................................................................................................................................. |
315 |
| 8 | -6.280 | [R] COG5271 AAA ATPase containing von Willebrand factor type A (vWA) domain |
ali follow.. |
11 | 118 | .....................................................................GNVFFNSHVPLPCSLVLTKSTQENLNRITPYLVQKRPILLAGPEGI-GKKFLITQIAAKL-----------------GQQIIRIHLSDSTDPKML-IGTYTSPK-VLTQAVITGKWILFTNIEHAPSEVLSVLLPLLEKRQLVIPSRGEGSFQMFATSSMKTKILGQRLWQILDLTYQPDECVEVVSTLYPVLSIICPTLYSVYKDIFDLFSQRSFLATSKIYRRLCLRDFYKFIKRVAFLYHKFMIPSDHVVISQELQDAVFKEAIDMFGAFIPSRDGFDLVVRNVAIELNIPPEKALQLRYSIPVFQNLEHNINIGRCSLKKLSTIRSCSTNSYAFTSSSLGLLEQLAAGVQTNEPLLLVGETGTGKTTTIQLLAGLLGQ |
493 |
| 9 | -5.550 | [I] KOG0693 Myo-inositol-1-phosphate synthase |
ali follow.. |
10 | 7 | ..............................STLEVISPKVQVDDEFITTD------YDYQTSHVKRTADGQL-------------QVHPQTTSLKIRTGRHVPKLGVMLVGWGGNNGSTLTAALEANRRQLKWRK-RTGVQEANWYGTQASTVFIGSDEDGGDVYVPMKELLPMVEPDNIIVDGWDILQDQIYDQLAQLRPRPSIYDRADNVIRGTRLEQYEQIRKD---IRDFRERSGVDSVIVLWTANTERFADVQPGLNTTSQELIASLEANHSEVSPSTIFAMAS----------IAEGCTYI----------------------NGSPQN--TFVPGLIQLAEEKNVFIAGDDFKSG--QTKIKSVLVDFLVGAGIKPVSIASYGNNDGKNLSAPQQFRSKEISKSNVVDDMV................................. |
368 |
| 10 | -5.280 | [T] COG0664 cAMP-binding proteins - catabolite gene activator and regulatory subunit of cAMP-dependent protein kinases |
ali follow.. |
12 | 29 | ......................SSSELDFVSRFKTGELAVESGSLYTVLHG---DGRRQILNYVMPGDLVGLQGTVMGEMEHSVEALSPVTLCVFERSRLNNLFTDHPTLAFD-SIGRRTAIERAAYLIAFLYRKAKAANLLPGETPIPVTQQHVAD--------LGLSIVHTNKTLRKLVDRGL-IRWIDKGCLVLDEAGLSHVAGWESDEKR............................................................................................................................................................................................................................................. |
245 |